Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Clinical Study of a UV-Absorbing Acrylic Posterior Chamber Intraocular Lens

NCT: NCT00625313 · COMPLETED

NCT IDNCT00625313
StatusCOMPLETED
Start Date2004-03
Completion2008-12
SponsorHoya Surgical Optics, Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

The purpose of this study is to assess the safety and efficacy of the HMY Model YA-60BB Intraocular Lens (IOL) when implanted in the posterior chamber of the human eye for the optical correction of aphakia following cataract extraction.

Frequently Asked Questions

What is Clinical Study of a UV-Absorbing Acrylic Posterior Chamber Intraocular Lens?

Clinical Study of a UV-Absorbing Acrylic Posterior Chamber Intraocular Lens is a clinical trial registered under NCT00625313. Current status: COMPLETED.

What is the status of NCT00625313?

The current status of NCT00625313 (Clinical Study of a UV-Absorbing Acrylic Posterior Chamber Intraocular Lens) is: COMPLETED.

When did Clinical Study of a UV-Absorbing Acrylic Posterior Chamber Intraocular Lens start?

Clinical Study of a UV-Absorbing Acrylic Posterior Chamber Intraocular Lens started on 2004-03.

Related Devices

PMA P080004intraocular lensHoya Surgical Optics, Inc. PMA P060011intraocular lensRayner Intraocular Lenses , Ltd. PMA P060022intraocular lensBausch & Lomb, Inc. PMA P090022intraocular lensLenstec, Inc. PMA P100016intraocular lensCarl Zeiss Meditec Production, LLC

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑